Boosters

New studies outline Omicron immune protection after infection, vaccination

Mon, 2023-01-09 23:37 — mike kraft

Studies detail Omicron immune protection after infection, vaccination One study looked at BA.5 infection after vaccination, while another examined vaccine effectiveness in children and adolescents. CIDRAP

A pair of new studies describe infection- and vaccine-conferred immunity against the SARS-CoV-2 Omicron variant, with one showing that vaccinated people have good protection against BA.5 subvariant reinfection for at least 8 months after infection, and the other finding that the vaccine is 46% and 70% effective against infection and hospitalization, respectively, in children.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about New studies outline Omicron immune protection after infection, vaccination
Log in or register to post comments

Florida surgeon general used ‘flawed’ science to discourage vaccinations -- university faculty peers

Thu, 2023-01-05 23:56 — mike kraft

Fla. surgeon general used ‘flawed’ vaccine science, faculty peers say Joseph A. Ladapo may have violated University of Florida research integrity rules, a faculty task force said.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

In China, vaccine hesitancy lingers even as COVID cases surge

Wed, 2023-01-04 02:40 — mike kraft

'I don't trust it:' Vaccine hesitancy lingers even as China COVID cases surge The problem is a growing headache for Beijing as it tries to persuade more people to get vaccinated in the face of a spike in infections and the prospect of more than 1.5 million deaths after the lifting of strict anti-COVID measures. David Kirton Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about In China, vaccine hesitancy lingers even as COVID cases surge
Log in or register to post comments

COVID booster prompts good immune response, except after recent infection --study

Wed, 2023-01-04 01:50 — mike kraft

COVID booster prompts good immune response, except after recent infection CIDRAP

A study today in Clinical Infectious Diseases finds that a third COVID-19 vaccine dose triggered a robust immune response, regardless of whether recipients had been infected more than 3 months earlier, but it didn't significantly increase antibody levels in those infected less than 3 months before.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about COVID booster prompts good immune response, except after recent infection --study
Log in or register to post comments

Updated Covid booster prevents most hospitalizations -- CDC new data

Sat, 2022-12-17 08:02 — mike kraft

Health Care — New CDC data backs up bivalent booster potency If you ever feel like your dog is judging, they just might be. New research found dogs can determine human aptitude, and they will look to people who they think are more competent. Today… jbyrnes The Hill

...

New data from the Centers for Disease Control and Prevention (CDC) show the bivalent COVID-19 booster shot was effective at reducing the risk of hospitalization and emergency room visits by at least 50 percent.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Updated Covid booster prevents most hospitalizations -- CDC new data
Log in or register to post comments

Why some adults aren't getting the COVID booster, a third of parents oppose school mandates --New polls

Fri, 2022-12-16 23:21 — mike kraft

New poll shows why some adults aren't getting the COVID booster The most common reason vaccinated people aren't getting a COVID booster is that they don't think they need one, a survey found. ABC News ABC News

...

More than a third, or 37%, said they didn't think the benefits are worth it. Another third, or 36%, said they were too busy or hadn't had time.

About a quarter said they didn't want to deal with bad side effects, while 17% said they were waiting to see if there would be a surge in their area first.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults - studies

Thu, 2022-12-15 23:27 — mike kraft

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies Ebola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday. Nandhini Srinivasan,Leroy Leo Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about J&J and Merck Ebola vaccines produce lasting antibodies in children and adults - studies
Log in or register to post comments

Omicron BQ, XBB subvariants evade boosters and antibody treatments -- study

Thu, 2022-12-15 21:20 — mike kraft

Omicron BQ, XBB subvariants are a serious threat to boosters and knock out antibody treatments, study finds

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Omicron BQ, XBB subvariants evade boosters and antibody treatments -- study
Log in or register to post comments

White House announces new COVID-19 prevention efforts, including free tests, vaccination clinics, support for nursing homes

Thu, 2022-12-15 20:51 — mike kraft

White House announces new COVID-19 prevention efforts, including free tests, vaccination clinics, support for nursing homes Biden administration announces new efforts to reduce COVID-19 as cases rise after Thanksgiving holiday. Will provide more tests, shots and treatments. Karen Weintraub USA TODAY

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

Researchers are calling for newer, better options for COVID vaccines

Thu, 2022-12-15 07:47 — mike kraft

Two years later, did Covid vaccines live up to their promise? Despite the success of mRNA vaccines, researchers think a new generation of Covid vaccines could provide broader, longer-term protection in the future. NBC News

...In particular, researchers think sprays or drops given through the nose or mouth could do a better job of stopping transmission. They also hope that vaccines that target multiple parts of the virus or several variants at once could reduce the need for continuous boosters.

...

Country / Region Tags:

General Topic Tags: